메뉴 건너뛰기




Volumn 8, Issue 11, 2013, Pages

Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CHEMOKINE CXCL10; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84894241678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080003     Document Type: Article
Times cited : (9)

References (42)
  • 3
    • 54549108005 scopus 로고    scopus 로고
    • Treatment of acute hepatitis C: The success of monotherapy with (pegylated) interferon alpha
    • Wiegand J, Deterding K, Cornberg M, Wedemeyer H (2008) Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. J Antimicrob Chemother 62: 860-865.
    • (2008) J Antimicrob Chemother , vol.62 , pp. 860-865
    • Wiegand, J.1    Deterding, K.2    Cornberg, M.3    Wedemeyer, H.4
  • 4
    • 19044361835 scopus 로고    scopus 로고
    • Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
    • DOI 10.1053/j.gastro.2005.01.059, PII S0016508505003999
    • Chen L, Borozan I, Feld J, Sun J, Tannis LL, et al. (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128: 1437-1444. (Pubitemid 40712193)
    • (2005) Gastroenterology , vol.128 , Issue.5 , pp. 1437-1444
    • Chen, L.1    Borozan, I.2    Feld, J.3    Sun, J.4    Tannis, L.-L.5    Coltescu, C.6    Heathcote, J.7    Edwards, A.M.8    McGilvray, I.D.9
  • 6
    • 36348960622 scopus 로고    scopus 로고
    • Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
    • Feld JJ, Nanda S, Huang Y, Chen W, Cam M, et al. (2007) Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. Hepatology.
    • (2007) Hepatology
    • Feld, J.J.1    Nanda, S.2    Huang, Y.3    Chen, W.4    Cam, M.5
  • 7
    • 70349292099 scopus 로고    scopus 로고
    • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
    • Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
    • (2009) Nature , vol.461 , pp. 399-401
    • Ge, D.1    Fellay, J.2    Thompson, A.J.3    Simon, J.S.4    Shianna, K.V.5
  • 8
    • 70349533037 scopus 로고    scopus 로고
    • Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    • Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
    • (2009) Nat Genet , vol.41 , pp. 1105-1109
    • Tanaka, Y.1    Nishida, N.2    Sugiyama, M.3    Kurosaki, M.4    Matsuura, K.5
  • 9
    • 70349548852 scopus 로고    scopus 로고
    • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
    • Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
    • (2009) Nat Genet , vol.41 , pp. 1100-1104
    • Suppiah, V.1    Moldovan, M.2    Ahlenstiel, G.3    Berg, T.4    Weltman, M.5
  • 10
    • 84862777615 scopus 로고    scopus 로고
    • Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype
    • McGilvray I, Feld JJ, Chen L, Pattullo V, Guindi M, et al. (2012) Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype. Gastroenterology 142: 1122-1131 e1121.
    • (2012) Gastroenterology , vol.142
    • McGilvray, I.1    Feld, J.J.2    Chen, L.3    Pattullo, V.4    Guindi, M.5
  • 11
    • 77955475888 scopus 로고    scopus 로고
    • Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C
    • Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, et al. (2010) Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139: 499-509.
    • (2010) Gastroenterology , vol.139 , pp. 499-509
    • Honda, M.1    Sakai, A.2    Yamashita, T.3    Nakamoto, Y.4    Mizukoshi, E.5
  • 12
    • 84873083416 scopus 로고    scopus 로고
    • A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
    • Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45: 164-171.
    • (2013) Nat Genet , vol.45 , pp. 164-171
    • Prokunina-Olsson, L.1    Muchmore, B.2    Tang, W.3    Pfeiffer, R.M.4    Park, H.5
  • 13
    • 33144462713 scopus 로고    scopus 로고
    • Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
    • DOI 10.1136/gut.2005.074062
    • Diago M, Castellano G, Garcia-Samaniego J, Perez C, Fernandez I, et al. (2006) Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55: 374-379. (Pubitemid 43268277)
    • (2006) Gut , vol.55 , Issue.3 , pp. 374-379
    • Diago, M.1    Castellano, G.2    Garcia-Samaniego, J.3    Perez, C.4    Fernandez, I.5    Romero, M.6    Iacono, O.L.7    Garcia-Monzon, C.8
  • 16
    • 34347336666 scopus 로고    scopus 로고
    • The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
    • DOI 10.1111/j.1365-2893.2006.00838.x
    • Zeremski M, Petrovic LM, Talal AH (2007) The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 14: 675-687. (Pubitemid 47414927)
    • (2007) Journal of Viral Hepatitis , vol.14 , Issue.10 , pp. 675-687
    • Zeremski, M.1    Petrovic, L.M.2    Talal, A.H.3
  • 17
    • 77951576906 scopus 로고    scopus 로고
    • Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
    • Askarieh G, Alsio A, Pugnale P, Negro F, Ferrari C, et al. (2010) Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology 51: 1523-1530.
    • (2010) Hepatology , vol.51 , pp. 1523-1530
    • Askarieh, G.1    Alsio, A.2    Pugnale, P.3    Negro, F.4    Ferrari, C.5
  • 18
    • 72249093341 scopus 로고    scopus 로고
    • Effective treatment of injecting drug users with recently acquired hepatitis C virus infection
    • Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, et al. (2010) Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 138: 123-135 e121-122.
    • (2010) Gastroenterology , vol.138
    • Dore, G.J.1    Hellard, M.2    Matthews, G.V.3    Grebely, J.4    Haber, P.S.5
  • 19
    • 84859164566 scopus 로고    scopus 로고
    • Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection
    • Grebely J, Pham ST, Matthews GV, Petoumenos K, Bull RA, et al. (2012) Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology 55: 1058-1069.
    • (2012) Hepatology , vol.55 , pp. 1058-1069
    • Grebely, J.1    Pham, S.T.2    Matthews, G.V.3    Petoumenos, K.4    Bull, R.A.5
  • 20
    • 84879080767 scopus 로고    scopus 로고
    • Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection
    • In Press
    • Grebely J, Feld JJ, Applegate T, Matthews GV, Hellard M, et al. (2013) Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology In Press.
    • (2013) Hepatology
    • Grebely, J.1    Feld, J.J.2    Applegate, T.3    Matthews, G.V.4    Hellard, M.5
  • 21
    • 84879080767 scopus 로고    scopus 로고
    • Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection
    • Grebely J, Feld JJ, Applegate T, Matthews GV, Hellard M, et al. (2013) Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology 57: 2124-2134.
    • (2013) Hepatology , vol.57 , pp. 2124-2134
    • Grebely, J.1    Feld, J.J.2    Applegate, T.3    Matthews, G.V.4    Hellard, M.5
  • 22
    • 77957965687 scopus 로고    scopus 로고
    • Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
    • Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, et al. (2010) Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology 52: 1216-1224.
    • (2010) Hepatology , vol.52 , pp. 1216-1224
    • Grebely, J.1    Petoumenos, K.2    Hellard, M.3    Matthews, G.V.4    Suppiah, V.5
  • 23
    • 79952097683 scopus 로고    scopus 로고
    • Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
    • Lagging M, Askarieh G, Negro F, Bibert S, Soderholm J, et al. (2011) Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms. Plos One 6: e17232.
    • (2011) Plos One , vol.6
    • Lagging, M.1    Askarieh, G.2    Negro, F.3    Bibert, S.4    Soderholm, J.5
  • 24
    • 78549268213 scopus 로고    scopus 로고
    • IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV
    • Falconer K, Askarieh G, Weis N, Hellstrand K, Alaeus A, et al. (2010) IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV. Scand J Infect Dis 42: 896-901.
    • (2010) Scand J Infect Dis , vol.42 , pp. 896-901
    • Falconer, K.1    Askarieh, G.2    Weis, N.3    Hellstrand, K.4    Alaeus, A.5
  • 25
    • 84864040447 scopus 로고    scopus 로고
    • Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection
    • Selvarajah S, Keating S, Heitman J, Lu K, Simmons G, et al. (2012) Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection. J Gen Virol 93: 1673-1679.
    • (2012) J Gen Virol , vol.93 , pp. 1673-1679
    • Selvarajah, S.1    Keating, S.2    Heitman, J.3    Lu, K.4    Simmons, G.5
  • 26
    • 78751492246 scopus 로고    scopus 로고
    • Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response
    • Darling JM, Aerssens J, Fanning G, McHutchison JG, Goldstein DB, et al. (2011) Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology 53: 14-22.
    • (2011) Hepatology , vol.53 , pp. 14-22
    • Darling, J.M.1    Aerssens, J.2    Fanning, G.3    McHutchison, J.G.4    Goldstein, D.B.5
  • 27
    • 78650962504 scopus 로고    scopus 로고
    • Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
    • Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, et al. (2011) Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest 121: 308-317.
    • (2011) J Clin Invest , vol.121 , pp. 308-317
    • Casrouge, A.1    Decalf, J.2    Ahloulay, M.3    Lababidi, C.4    Mansour, H.5
  • 28
    • 78049469161 scopus 로고    scopus 로고
    • A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice
    • Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, et al. (2010) A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139: 1586-1592, 1592 e1581.
    • (2010) Gastroenterology , vol.139
    • Tillmann, H.L.1    Thompson, A.J.2    Patel, K.3    Wiese, M.4    Tenckhoff, H.5
  • 29
    • 84865460821 scopus 로고    scopus 로고
    • Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C
    • Dill MT, Makowska Z, Duong FH, Merkofer F, Filipowicz M, et al. (2012) Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C. Gastroenterology 143: 777-786 e771-776.
    • (2012) Gastroenterology , vol.143
    • Dill, M.T.1    Makowska, Z.2    Duong, F.H.3    Merkofer, F.4    Filipowicz, M.5
  • 30
    • 68849111675 scopus 로고    scopus 로고
    • Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence
    • Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745-1754.
    • (2009) J Clin Invest , vol.119 , pp. 1745-1754
    • Rehermann, B.1
  • 31
    • 84870454347 scopus 로고    scopus 로고
    • Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection
    • Feld JJ (2012) Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection. Best Pract Res Clin Gastroenterol 26: 429-444.
    • (2012) Best Pract Res Clin Gastroenterol , vol.26 , pp. 429-444
    • Feld, J.J.1
  • 32
    • 33644875265 scopus 로고    scopus 로고
    • Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies
    • Micallef JM, Kaldor JM, Dore GJ (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13: 34-41.
    • (2006) J Viral Hepat , vol.13 , pp. 34-41
    • Micallef, J.M.1    Kaldor, J.M.2    Dore, G.J.3
  • 33
    • 68849096074 scopus 로고    scopus 로고
    • Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43
    • Sarasin-Filipowicz M, Wang X, Yan M, Duong FH, Poli V, et al. (2009) Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol Cell Biol 29: 4841-4851.
    • (2009) Mol Cell Biol , vol.29 , pp. 4841-4851
    • Sarasin-Filipowicz, M.1    Wang, X.2    Yan, M.3    Duong, F.H.4    Poli, V.5
  • 34
    • 79953732320 scopus 로고    scopus 로고
    • Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo
    • Makowska Z, Duong FH, Trincucci G, Tough DF, Heim MH (2011) Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo. Hepatology 53: 1154-1163.
    • (2011) Hepatology , vol.53 , pp. 1154-1163
    • Makowska, Z.1    Duong, F.H.2    Trincucci, G.3    Tough, D.F.4    Heim, M.H.5
  • 35
    • 79960313095 scopus 로고    scopus 로고
    • USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response
    • Francois-Newton V, Magno de Freitas Almeida G, Payelle-Brogard B, Monneron D, Pichard-Garcia L, et al. (2011) USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response. PLoS One 6: e22200.
    • (2011) PLoS One , vol.6
    • Francois-Newton, V.1    Magno De Freitas Almeida, G.2    Payelle-Brogard, B.3    Monneron, D.4    Pichard-Garcia, L.5
  • 37
    • 82455188188 scopus 로고    scopus 로고
    • Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures
    • Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, et al. (2011) Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 54: 1913-1923.
    • (2011) Hepatology , vol.54 , pp. 1913-1923
    • Marukian, S.1    Andrus, L.2    Sheahan, T.P.3    Jones, C.T.4    Charles, E.D.5
  • 40
    • 78751545582 scopus 로고    scopus 로고
    • Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models
    • Thomas E, Feld JJ, Li Q, Hu Z, Fried MW, et al. (2011) Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. Hepatology 53: 32-41.
    • (2011) Hepatology , vol.53 , pp. 32-41
    • Thomas, E.1    Feld, J.J.2    Li, Q.3    Hu, Z.4    Fried, M.W.5
  • 41
    • 77953893773 scopus 로고    scopus 로고
    • Ribavirin improves early responses to peginterferon through improved interferon signaling
    • Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, et al. (2010) Ribavirin improves early responses to peginterferon through improved interferon signaling. Gastroenterology 139: 154-162 e154.
    • (2010) Gastroenterology , vol.139
    • Feld, J.J.1    Lutchman, G.A.2    Heller, T.3    Hara, K.4    Pfeiffer, J.K.5
  • 42
    • 11144330097 scopus 로고    scopus 로고
    • Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
    • DOI 10.1038/nature03153
    • Dixit NM, Layden-Almer JE, Layden TJ, Perelson AS (2004) Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 432: 922-924. (Pubitemid 40037156)
    • (2004) Nature , vol.432 , Issue.7019 , pp. 922-924
    • Dixit, H.M.1    Layden-Almer, J.E.2    Layden, T.J.3    Perelson, A.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.